Results 21 to 30 of about 193,929 (276)
Cytokine release syndrome in severe COVID-19 [PDF]
Science, 2020 Lessons from arthritis and cell therapy in cancer patients point to therapy for severe ...
Moore, John B., June, Carl H.
openaire +2 more sources
Pathogens, 2021 The purpose of this systematic review was to describe the characteristics of clinical trials that focused on COVID-19 patients with cytokine release syndrome (CRS) and the variability in CRS definitions.
Khalid Eljaaly +5 more
doaj +1 more source
The Many Faces of JAKs and STATs Within the COVID-19 Storm
Frontiers in Immunology, 2021 The positive-sense single stranded RNA virus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), resulted in a global pandemic with horrendous health and economic consequences not seen in a century.
Alice H. Grant +8 more
doaj +1 more source
Geriatrics, 2022 The new coronavirus disease 2019 (COVID-19) could be associated with elevated inflammatory cytokine levels, suggesting the involvement of cytokine release syndrome.
Cid Ould Ouali +10 more
doaj +1 more source
COVID-19-associated cytokine storm syndrome and diagnostic principles: an old and new Issue
Emerging Microbes and Infections, 2021 SARS-CoV-2 has claimed 2,137,908 lives in more than a year. Some COVID-19 patients experience sudden and rapid deterioration with the onset of fatal cytokine storm syndrome (CSS), which have increased interest in CSS’s mechanisms, diagnosis and therapy ...
Xi Yongzhi
doaj +1 more source
Cardiovascular Complications of Chimeric Antigen Receptor T-Cell Therapy: The Cytokine Release Syndrome and Associated Arrhythmias [PDF]
Journal of Immunotherapy and Precision Oncology, 2020 In recent years, cancer treatment has evolved, and new therapies have been introduced with significant improvement in prognosis. The immunotherapies stand out owing to their efficacy and remission rate. Chimeric antigen receptor (CAR) T-cell therapy is a
Cesar Clavijo Simbaqueba +9 more
doaj +1 more source
Highly sensitive in vitro cytokine release assay incorporating high-density preculture
Journal of Immunotoxicology, 2021 Immunostimulatory effects of monoclonal antibodies (mAb) through binding to Fcγ receptors (FcγR) on immune cells are a likely cause of cytokine release syndrome.
Shiho Ito +5 more
doaj +1 more source
STAT: Cytokine Release Syndrome
Clinical Journal of Oncology Nursing, 2020 Cytokine release syndrome is a systemic inflammatory condition that may occur after treatment with some types of immunotherapy.
openaire +3 more sources
Interleukin Inhibitors in Cytokine Release Syndrome and Neurotoxicity Secondary to CAR-T Therapy
Diseases, 2022 Introduction: Chimeric antigen receptor T-cell (CAR-T) therapy is an innovative therapeutic option for addressing certain recurrent or refractory hematological malignancies.
Puri Ferreros, Isabel Trapero
doaj +1 more source
Cytokine Release Syndrome: An Overview on its Features and Management
Journal of Pure and Applied Microbiology, 2019 Cytokine release syndrome (CRS) is a life threatening toxicity associated numerous immunotherapeutic techniques involving monoclonal antibodies, bispecific antibodies and adoptive T cell therapies. It is also referred as infusion reaction that results in
Shailza Shreshtha +3 more
doaj +1 more source